ENOV Enovis Corporation

Enovis is a medical technology growth company dedicated to developing clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. Our mission is to fuel active lifestyles in orthopedics and beyond.

$46.22  -1.04 (-2.20%)
As of 09/27/2022 15:59:51 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Mid cap
GICS sector:  Health Care
Industry:  Specialty Industrial Machinery
Index country:  USA
Country of incorporation:  USA
IPO date:  05/08/2008
Outstanding shares:  54,129,530
Average volume:  493,057
Market cap:   $2,601,465,212
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BJLTMX5
Valuation   (See tab for details)
PE ratio:   38.45
PB ratio:   0.56
PS ratio:   0.65
Return on equity:   1.47%
Net income %:   1.69%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy